Insider Trading › RDHL › Insiders
RedHill Biopharma Ltd.
RDHL·Nasdaq·
Israel·Insider activity
Israel·Insider activity$0.48
-0.01 (-1.79%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
RDHL
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
RDHLS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, RDHL insiders filed 0 purchases ($0) and 3 sales ($0) on the open market, by 1 insider. Newest filing Oct 6, 2026 (yesterday).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by RDHL insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$0Sales · 180 days
3Open-market transactions on record
1Insiders filing · 180 days
Purchases (code P) and sales (code S) of RDHL common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
3 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Raday GileadChief Operating Officer | Sale | −14.3M | n/c | — | 176.9Mdirect | Oct 1, 2026 | Oct 6, 2026 | Form 4 ↗ |
| Raday GileadChief Operating Officer | Sale | −14.1M | n/c | — | 218.8Mdirect | Jul 10, 2026 | Jul 13, 2026 | Form 4 ↗ |
| Raday GileadChief Operating Officer | Sale | −15.7M | $0.00 | $0 | 261.1Mdirect | Apr 6, 2026 | Apr 22, 2026 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →